, saying industry veteran Tim Wentworth is the right choice to lead the struggling pharmacy chain in its transition to offering more health-care services.
"This guy is the real deal. I just salute him and think he can take you to a higher price, and the stock should be bought — perhaps aggressively," Cramer said onafter former chief executive Roz Brewer left her post. The company said it was seeking a new CEO who had "deep" experience in the health-care industry.
Shares of Walgreens rose more than 1% Wednesday, to $22.66. However, so far in 2023, the Dow Jones Industrial Average constituent is down nearly 40%.Jim's Charitable Trust